Efficacy of morphological indexing of ovarian tumor: preoperative determination of risk of malignancy

Authors

  • Jagan Aishwarya Department of Obstetrics and Gynecology, Government Rajaji Hospital, Madurai Medical College, Madurai, India
  • Ramasamy Sasikala Department of Obstetrics and Gynecology, Government Rajaji Hospital, Madurai Medical College, Madurai, India
  • Syed Dilshath Department of Obstetrics and Gynecology, Government Rajaji Hospital, Madurai Medical College, Madurai, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20173463

Keywords:

Morphological indexing, Malignancy, Ovarian tumour

Abstract

Background: Ovarian cancers ranks fifth in cancer death worldwide and in India it ranks third among the female genital tract malignancies. Objective of present study was to assess prospectively the efficacy of morphological indexing (MI) as a method to predict malignancy in sonographically confirmed ovarian tumors.

Methods: A prospective study conducted in a tertiary care hospital in Tamil Nadu from September 2011 to August 2012.  The risk of malignancy is preoperatively assessed in 136 patients with ovarian tumour using a morphological index based on tumour volume and wall structure. Each tumour was assigned a score of 0 to 10 based on increasing volume and morphologic complexity. The efficacy of the index was assessed by histopathological examination of the tumour.

Results: The benign tumours had a mean MI score of 4.3 and malignant tumours had a mean of 8.3 which was statistically significant. Of the 54 tumours with MI <5, only 2 (3.7%) were malignant where else out of the remaining 82 tumours with MI >5, 54 (51.2%) were malignant. With MI >5 as a predictor of malignancy the present study had a Sensitivity-95.5%, Specificity-56.5%, Positive predictive value-51.2%, Negative predictive value-94%, and Accuracy-68%.

Conclusions: Morphological index is a simple, valuable and inexpensive diagnostic tool to rule out malignancy in pre operative evaluations of ovarian tumors.

References

Cancer Incidence in Five Continents - WHO - OMS - [Internet]. [cited 2017 May 17]. Available at http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=73&codcch=143

Murthy NS, Shalini S, Suman G, Pruthvish S, Mathew A. Changing trends in incidence of ovarian cancer - the Indian scenario. Asian Pac J Cancer Prev. 2009;10(6):1025-30.

3. Takiar R, Nadayil D, Nandakumar A. Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev. 2010;11(4):1045-9.

van Nagell JR, DePriest PD, Gallion HH, Pavlik EJ. Ovarian cancer screening. Cancer. 1993;71(4 Suppl):1523-8.

Yelikar KA, Deshpande SS, Nanaware SS, Pagare SB. Evaluation of the validity of risk malignancy index in clinically diagnosed ovarian masses and to compare it with the validity of individual constituent parameter of risk malignancy index. Int J Reprod Contracept Obstet Gynecol. 2016;5(2):460-4.

DePriest PD, Shenson D, Fried A, Hunter JE, Andrews SJ, Gallion HH, et al. A morphology index based on sonographic findings in ovarian cancer. Gynecol Oncol. 1993;51(1):7-11.

Partridge EE, Barnes MN. Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J Clin. 1999;49(5):297-320.

Sassone AM, Timor-Tritsch IE, Artner A, Westhoff C, Warren WB. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol. 1991;78(1):70-6.

DePriest PD, Varner E, Powell J, Fried A, Puls L, Higgins R, et al. The efficacy of a sonographic morphology index in identifying ovarian cancer: a multi-institutional investigation. Gynecol Oncol. 1994;55(2):174-8.

Lerner JP, Timor-Tritsch IE, Federman A, Abramovich G. Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. Am J Obstet Gynecol. 1994;170(1 Pt 1):81-5.

Ferrazzi E, Zanetta G, Dordoni D, Berlanda N, Mezzopane R, Lissoni AA et al. Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study. Ultrasound Obstet Gynecol. 1997;10(3):192-7.

Bailey CL, Ueland FR, Land GL, DePriest PD, Gallion HH, Kryscio RJ et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol. 1998;69(1):3-7.

Ueland FR, DePriest PD, Pavlik EJ, Kryscio RJ, van Nagell JR. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography. Gynecol Oncol. 2003;91(1):46-50.

Trimbos JB, Hacker NF. The case against aspirating ovarian cysts. Cancer. 1993;72(3):828-31.

Granberg S, Norström A, Wikland M. Tumors in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol. 1990;37(2):224-9.

Yamashita Y, Hatanaka Y, Torashima M, Takahashi M, Miyazaki K, Okamura H. Characterization of sonographically indeterminate ovarian tumors with MR imaging. A logistic regression analysis. Acta Radiol. 1997;38(4 Pt 1):572-7.

Downloads

Published

2017-07-26

Issue

Section

Original Research Articles